News

CMN Weekly (10 December 2021) - Your Weekly CRISPR Medicine News

Some of the best links we picked up around the internet

By: Gorm Palmgren - Dec. 10, 2021
News

Top Picks

Research

Industry

Detection

Reviews

Commentary

Huh, Heh, Wow

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN WeeklyHashtagLipid-based nanoparticleHashtagAdeno-associated virus (AAV)HashtagChronic Hepatitis B, HBVHashtagAutoimmune diseaseHashtagBlood diseaseHashtagCancerHashtagEthics in Genome editingHashtagGene therapyHashtagPolicyHashtagARCUSHashtagCas9HashtagMetagenomiHashtagPrecision BioSciences, Inc.

News: CMN Weekly (10 December 2021) - Your Weekly CRISPR Medicine News
CLINICAL TRIALS
Beta-Thalassemia, BT, (NCT06024876)
Sponsors:
CorrectSequence Therapeutics Co., Ltd
Indicator
IND Enabling
Phase I
Phase II
Phase III
Transfusion-dependent Beta-Thalassemia, TDT, (NCT06065189)
Sponsors:
Children's Hospital of Fudan University
Indicator
IND Enabling
Phase I
Phase II
Phase III
Transfusion-dependent Beta-Thalassemia, TDT, (NCT06291961)
Sponsors:
CorrectSequence Therapeutics Co., Ltd
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine